首页> 外文期刊>Arthritis Research >Adipose-derived mesenchymal stem cells from the sand rat: transforming growth factor beta and 3D co-culture with human disc cells stimulate proteoglycan and collagen type I rich extracellular matrix
【24h】

Adipose-derived mesenchymal stem cells from the sand rat: transforming growth factor beta and 3D co-culture with human disc cells stimulate proteoglycan and collagen type I rich extracellular matrix

机译:来自沙鼠的脂肪来源的间充质干细胞:转化生长因子β和3D与人圆盘细胞的共培养刺激蛋白聚糖和富含I型胶原的细胞外基质

获取原文
           

摘要

Introduction Adult mesenchymal stem cell therapy has a potential application in the biological treatment of disc degeneration. Our objectives were: to direct adipose-derived mesenchymal stem cells (AD-MSC) from the sand rat to produce a proteoglycan and collagen type I extracellular matrix (ECM) rich in known ECM components of the annulus fibrosis of disc; and to stimulate proteoglycan production by co-culture of human annulus cells with AD-MSC. Methods AD-MSC were isolated and characterised by adherence to plastic, appropriate expression of cluster of differentiation (CD) markers, and differentiation to osteoblasts and chondrocytes in vitro . AD-MSC were grown in three-dimensional (3D) culture and treated with or without transforming growth factor beta (TGFβ) to direct them to produce annulus-like ECM as determined by proteoglycan content and collagen expression. AD-MSC were co-cultured with human annulus cells and grown in 3D culture. Results AD-MSC produced a proteoglycan and collagen type I rich ECM after treatment with TGFβ in 3D culture as confirmed by a 48% increase in proteoglycan content assayed by 1,9-dimethylmethylene blue (DMB), and by immunohistochemical identification of ECM components. Co-culture of human annulus and sand rat AD-MSC in 3D culture resulted in a 20% increase in proteoglycan production compared with the predicted value of the sum of the individual cultures. Conclusion Results support the hypothesis that AD-MSC have potential in cell-based therapy for disc degeneration.
机译:简介成人间充质干细胞疗法在椎间盘退变的生物学治疗中具有潜在的应用。我们的目标是:引导来自沙鼠的脂肪来源的间充质干细胞(AD-MSC)产生富含多糖和椎间盘纤维化的已知ECM成分的蛋白聚糖和I型胶原细胞外基质(ECM);并通过与AD-MSC共培养人环细胞来刺激蛋白聚糖的产生。方法对AD-MSC进行体外分离和鉴定,方法是坚持塑性,适当表达分化簇(CD)标记,并向成骨细胞和软骨细胞分化。 AD-MSC在三维(3D)培养中生长,并用或不用转化生长因子β(TGFβ)进行处理,以指导它们产生通过蛋白聚糖含量和胶原蛋白表达确定的环样ECM。 AD-MSC与人环细胞共培养,并在3D培养中生长。结果AD-MSC在3D培养物中用TGFβ处理后产生了富含蛋白聚糖和I型胶原的ECM,通过1,9-二甲基亚甲基蓝(DMB)测定的蛋白聚糖含量增加了48%,并通过免疫组织化学鉴定ECM成分证实了AD-MSC。与单个培养物总和的预测值相比,在3D培养物中人环和沙鼠AD-MSC的共培养导致蛋白聚糖产量增加20%。结论结果支持以下假设:AD-MSC在基于细胞的椎间盘退变治疗中具有潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号